GGrantIndex
Sort

78,016 grants matching breast cancer

Prevalence effects in visual research: Theoretical and practical implications

$434,075
Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2022 · EY

Pharmacogenetics of Hormonal Therapy for Breast Cancer

$434,047
Susan Ann Kadlubar · Univ Of Arkansas For Med Scis · R01 · FY2009 · CA

Cyclin A Function in Normal Proliferation and in Neoplasia

$434,038
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2012 · CA

Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer

$434,033
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA

Vermont Screening Process Documentation Unit

$434,007
Brian L Sprague · University Of Vermont & St Agric College · U54 · FY2012 · CA

Three-dimensional organoid models to study breast cancer progression

$434,007
Shilpa Sant · University Of Pittsburgh At Pittsburgh · R37 · FY2021 · CA

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

$434,000
Dhruv Singhal · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

$434,000
Dhruv Singhal · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

$434,000
Dhruv Singhal · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

$434,000
Dhruv Singhal · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL

Methods for Etiologic Studies of Diet and Cancer

$433,986
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis

$433,981
Da Yang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

TRAIL-induced Cell Death in Breast Cancer Cells

$433,959
Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Nanofluidics Devices for Rapid Single Cell Analysis of Protein Expression

$433,943
John M Ramsey · Univ Of North Carolina Chapel Hill · U54 · FY2009 · CA

GSTP1 as a therapeutic target for pancreatic cancer

$433,934
Katie Reindl · North Dakota State University · R15 · FY2020 · CA

Hedgehog signaling in head and neck cancer stem cells, and its role in resistance

$433,933
Antonio Jimeno · University Of Colorado Denver · R01 · FY2010 · CA

Activation of the beta-3 integrins: Role of the kindlins

$433,909
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL

Targeting Notch, PI3K-AKT and Other Novel Pathways in Breast Cancer Stem Cells

$433,884
Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2012 · CA

THE ROLE OF PAUSES RNA POLYMERASE II IN BREAST CANCER

$433,884
Ohio State University, The · · FY2010 · Department of the Army

Development of a PEM-PET-CT Breast Imaging and Biopsy Device

$433,867
Raymond Robert Raylman · West Virginia University · R01 · FY2013 · CA

Ponce School of Medicine - Moffitt Cancer Center Partner

$433,867
Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2007 · CA

Mechanism of Action of Estrogens and Antiestrogens

$433,853
Donald P McDonnell · Duke University · R37 · FY2007 · DK

Exosomes in tumor cell-mesenchymal stromal cell interaction

$433,850
Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2021 · CA

OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING

$433,832
Jeanne Mandelblatt · Georgetown University · U01 · FY2013 · CA

Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer

$433,830
Thomas V O'Halloran · Northwestern University At Chicago · U01 · FY2011 · CA